Drug General Information
Drug ID
D0I5VA
Former ID
DPR000174
Drug Name
CF502
Drug Type
Small molecular drug
Indication Inflammation [ICD10:E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89] Preclinical [540970], [550529]
Company
Can-Fite BioPharm
Structure
Download
2D MOL
Formula
C20H20Cl2N6O3
InChI
InChI=1S/C20H20Cl2N6O3/c1-23-18(31)20-6-11(20)13(14(29)15(20)30)28-8-25-12-16(26-19(22)27-17(12)28)24-7-9-3-2-4-10(21)5-9/h2-5,8,11,13-15,29-30H,6-7H2,1H3,(H,23,31)(H,24,26,27)/t11-,13-,14+,15+,20+/m1/s1
InChIKey
GAYWHRPOIWFKIF-DDDALXFXSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Adenosine A3 receptor Target Info Agonist [550529]
Reactome Adenosine P1 receptors
G alpha (i) signalling events
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
GPCRs, Other
References
Ref 540970(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5601).
Ref 5505292011 Pipeline of Can-Fite BioPharm.
Ref 5505292011 Pipeline of Can-Fite BioPharm.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.